Jessica Fye

Q: What is Jessica Fye's success rate?

Jessica Fye currently has a success rate of 88.65789815882094.

Q: What is the average return of Jessica Fye's calls?

Their stock ratings have generated an average return of 20.498612279123194.

JP Morgan | Healthcare

Jessica Fye is an analyst from JP Morgan specializing in the Healthcare sector. Ranked #1211 out of 4773 analysts, they have issued 41 stock ratings with a success rate of 88.66% and an average return of 20.50%.

Jessica Fye has a well-established track record, with 41 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.66% and an average return of 20.50%, underscoring their expertise and ability to identify winning opportunities for investors.

#1211

Out of 4773

Total Ratings

+88.66%

Success Rate

+20.50%

Average Return

Recent Ratings Analysis

AMRN

Sell

Aug 21, 2026

Target

$13.00

Current

$13.80

Performance

-2.06%

Jessica Fye rated AMRN as Underweight on Aug 21, 2026, setting a price target of 13. So far, the bearish outlook hasn’t materialized, with shares flat near 13.8.

STOK

Buy

Aug 21, 2026

Target

$40.00

Current

$29.03

Performance

-10.10%

On Aug 21, 2026, STOK was given a Overweight rating by Jessica Fye, with a target price of 40. Despite the Buy call, shares fell from 29.03 to 29.03, challenging the optimistic stance.

NKTR

Hold

Aug 21, 2026

Target

$65.00

Current

$69.76

Performance

-5.76%

NKTR received a Neutral rating from Jessica Fye on Aug 21, 2026, aiming for 65. The Hold stance proved prudent, with the market softening by 5.76%.

MRNA

Sell

Aug 21, 2026

Target

$77.00

Current

$143.97

Performance

-0.80%

On Aug 21, 2026, Jessica Fye published a Underweight outlook on MRNA, with a target of 77. The rating remains inconclusive as the market consolidates near 143.97.

MBX

Buy

Aug 21, 2026

Target

$88.00

Current

$59.02

Performance

-11.02%

Jessica Fye on Aug 21, 2026 assigned MBX a Overweight rating, with a price target of 88. The call has struggled to gain traction, with shares losing 11.02%.

IMCR

Buy

Aug 21, 2026

Target

$50.00

Current

$32.60

Performance

-11.61%

On Aug 21, 2026, Jessica Fye reaffirmed IMCR with a Overweight rating, targeting 50. Shares slid 11.61% despite the recommendation, highlighting downside risks.

JAZZ

Buy

Aug 04, 2026

Target

$276.00

Current

$245.80

Performance

-6.05%

JAZZ was rated Overweight by Jessica Fye on Aug 04, 2026, with a price objective of 276. This case shows how bullish projections can fail, with the stock now below 245.8.

IONS

Buy

Aug 03, 2026

Target

$76.00

Current

$54.21

Performance

-0.51%

On Aug 03, 2026, Jessica Fye initiated coverage on IONS with a Overweight rating and target of 76. Neutral price movement of -0.51% leaves room for interpretation.

ALNY

Buy

Jul 31, 2026

Target

$375.00

Current

$248.68

Performance

21.00%

Jessica Fye issued a Overweight recommendation for ALNY on Jul 31, 2026, price target set at 375. Investors following the Buy call captured upside momentum, with shares now at 248.68.

ALKS

Hold

Jul 29, 2026

Target

$61.00

Current

$45.97

Performance

-4.90%

On Jul 29, 2026, ALKS was evaluated by Jessica Fye, who gave a Neutral rating and target of 61. Hold sentiment was validated by subdued trading with no breakout beyond 45.97.

ONC

Buy

Jul 23, 2026

Target

$425.00

Current

$346.51

Performance

6.04%

Jessica Fye rated ONC as Overweight on Jul 23, 2026, setting a price target of 425. The call has proven timely, with shares rising 6.04% toward the price target of 425.

UTHR

Buy

Jul 23, 2026

Target

$687.00

Current

$497.11

Performance

-6.12%

On Jul 23, 2026, UTHR was given a Overweight rating by Jessica Fye, with a target price of 687. Despite the Buy call, shares fell from 497.11 to 497.11, challenging the optimistic stance.

INCY

Hold

Jul 23, 2026

Target

$110.00

Current

$121.47

Performance

4.10%

INCY received a Neutral rating from Jessica Fye on Jul 23, 2026, aiming for 110. Shares remained flat at 121.47, aligning with the neutral rating.

AKTS

Buy

Jul 14, 2026

Target

$33.00

Current

$23.30

Performance

-7.47%

On Jul 14, 2026, Jessica Fye published a Overweight outlook on AKTS, with a target of 33. Market action contradicted the Buy thesis, as shares slipped to 23.3.

NVCR

Hold

Jul 13, 2026

Target

$17.00

Current

$15.51

Performance

-3.60%

Jessica Fye on Jul 13, 2026 assigned NVCR a Neutral rating, with a price target of 17. The Hold stance reflected consolidation, as shares held near 15.51.

LEGN

Hold

Jul 13, 2026

Target

$35.00

Current

$18.64

Performance

-27.61%

On Jul 13, 2026, Jessica Fye reaffirmed LEGN with a Neutral rating, targeting 35. The Hold stance reflected market caution that was later justified.

DNLI

Buy

Jul 13, 2026

Target

$29.00

Current

$21.09

Performance

-20.35%

DNLI was rated Overweight by Jessica Fye on Jul 13, 2026, with a price objective of 29. This case shows how bullish projections can fail, with the stock now below 21.09.

BCRX

Hold

Jul 13, 2026

Target

$12.00

Current

$8.12

Performance

-18.06%

On Jul 13, 2026, Jessica Fye initiated coverage on BCRX with a Neutral rating and target of 12. The rating matched the stock’s inability to hold above 8.12.

MIRM

Buy

Jul 02, 2026

Target

$125.00

Current

$98.22

Performance

-21.79%

Jessica Fye issued a Overweight recommendation for MIRM on Jul 02, 2026, price target set at 125. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

INSM

Buy

Jun 08, 2026

Target

$179.00

Current

$129.41

Performance

37.42%

On Jun 08, 2026, INSM was evaluated by Jessica Fye, who gave a Overweight rating and target of 179. This case illustrates how a timely bullish rating can translate into tangible gains of 37.42%.

HALO

Hold

Oct 27, 2025

Target

$65.00

Current

$107.20

Performance

62.79%

Jessica Fye rated HALO as Neutral on Oct 27, 2025, setting a price target of 65. Despite the Hold call, shares climbed 62.79% to 107.2, revealing unexpected momentum.

BNTX

Hold

Oct 23, 2025

Target

$120.00

Current

$96.73

Performance

-7.66%

On Oct 23, 2025, BNTX was given a Neutral rating by Jessica Fye, with a target price of 120. The rating provided protection from downside risk as the stock fell to 96.73.

BMRN

Buy

Oct 09, 2025

Target

$119.00

Current

$65.68

Performance

21.97%

BMRN received a Overweight rating from Jessica Fye on Oct 09, 2025, aiming for 119. Momentum has favored the Buy call, with shares climbing from 65.68 to 65.68, rewarding those who trusted the recommendation.

ASND

Buy

Oct 09, 2025

Target

$264.00

Current

$263.51

Performance

22.70%

On Oct 09, 2025, Jessica Fye published a Overweight outlook on ASND, with a target of 264. Shares gained 22.70%, underscoring the accuracy of the bullish outlook toward 264.

VRTX

Buy

Oct 08, 2025

Target

$530.00

Current

$515.44

Performance

22.39%

Jessica Fye on Oct 08, 2025 assigned VRTX a Overweight rating, with a price target of 530. The Buy call aligned well with market performance, producing a gain of 22.39%.

CRNX

Buy

Sep 24, 2025

Target

$52.00

Current

$84.95

Performance

141.47%

On Sep 24, 2025, Jessica Fye reaffirmed CRNX with a Overweight rating, targeting 52. The recommendation was supported by strong follow-through as the stock rose from 84.95 to 84.95.

ITCI

Buy

Aug 21, 2024

Target

$81.00

Current

$131.87

Performance

74.22%

ITCI was rated Overweight by Jessica Fye on Aug 21, 2024, with a price objective of 81. A bullish response from the market helped close the gap of -50.87 to the target.

BGNE

Buy

Aug 20, 2024

Target

$200.00

Current

$184.71

Performance

-4.89%

On Aug 20, 2024, Jessica Fye initiated coverage on BGNE with a Overweight rating and target of 200. Neutral price movement of -4.89% leaves room for interpretation.

Frequency Asked Questions

Who is Jessica Fye?

Jessica Fye is an analyst from JP Morgan specializing in the Healthcare sector.

What is Jessica Fye's success rate?

Jessica Fye currently has a success rate of +88.66%.

How many ratings has Jessica Fye issued?

Jessica Fye has issued 41 stock ratings so far.

What is the average return of Jessica Fye's calls?

Their stock ratings have generated an average return of +20.50%.

What is Jessica Fye's ranking?

Jessica Fye is ranked #1211 out of 4773 analysts.

What types of ratings does Jessica Fye give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Jessica Fye?

You can follow Jessica Fye by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Jessica Fye?

Their latest rating was a Sell on AMRN issued on 2026-08-21.